Skip to Main Content

Paper Details

TLR9 plus STING Agonist Adjuvant Combination Induces Potent Neopeptide T Cell Immunity and Improves Immune Checkpoint Blockade Efficacy in a Tumor Model.
J Immunol
0
2024
Author NameAffiliation
Harmen J G van de WerkenDepartment of Immunology Erasmus University Medical Center
  • 1 - 1

Datasets

Release 1.2